Hemophilia and Thrombosis: Referral Directory
Kaye Schmidt, RN, MA, CPON, NEA-BC
Description of services:
Comprehensive diagnostic and treatment program for patients with disorders of blood coagulation which results in increased risk of bleeding or clotting, including a focus on the following:
- Parent and patient education.
- Prevention of hemorrhage by means of prophylactic factor infusions.
- Insertion and maintenance of intravenous access devices
- Treatment of musculoskeletal complications of hemophilia (physical therapy programs, arthroscopic synovectomy, etc.)
- Monitoring for viral infections, a complicating factor of replacement therapy.
- Psychosocial and financial assistance.
- Management of patients with increased blood clotting, including arterial and venous thrombosis, catheter-associated blood clots, thrombotic strokes and hereditary clotting disorders (thrombophilia).
- Monitoring anticoagulation therapy.
- Transition program for older adolescents and young adults with coagulation disorders.
- Acquired blood coagulation disorders.
- Hereditary and acquired thrombotic disorders.
The Pediatric Hemophilia and Thrombosis Center is a component of the North Texas Comprehensive Hemophilia Center, which receives federal funding from the Maternal and Child Health Bureau and the Centers for Disease Control and Prevention.
For more information, log on to Center for Cancer and Blood Disorders.
Procedures performed or problems diagnosed and treated:
Consultative diagnostic and management services for infants, children and adolescents with the following conditions:
- Congenital FVIII and IX deficiency
- von Willebrand disease
- Qualitative disorders of platelets
- Other hereditary bleeding disorders
- Assessment of children suspected of having a bleeding disorder on the basis of an abnormal laboratory test (prolonged PTT) or signs/symptoms (recurrent epistaxis, easy bruising, positive family history, etc.)
- Venous and arterial thrombosis
- Catheter-related thrombosis
- Familial prothrombotic disorders, including Protein C & S deficiency and Factor V Leiden & Prothrombin G20210A mutations.
Information for referral sources:
- A referral from physician or referral source is required.
- Patient instructions for specific tests will be provided when the appointment is scheduled.
- To avoid unnecessary testing, have the family bring relevant medical records, test results and X-rays to the appointment.
- Services are provided in close cooperation with the patient's referring physician.
- Diagnosis, evaluation and recommended treatment information is provided promptly to the referring physician.
After hours or for emergencies, call 214-456-7000 and request the hematologist-oncologist on call.
Please provide the following when calling to schedule a patient for a diagnostic evaluation:
- Patient name and date of birth
- Probable diagnosis
- Insurance/referral information
- Physician clinical findings or symptoms which caused the patient to visit physician
- Parent (guarantor) name, address and phone number
Why Children's Medical Center?
- Since the late 1970s the hemophilia and thrombosis program at Children's has been the leader in North Texas responsible for the diagnosis and management of hereditary and acquired bleeding disorders during childhood.
- A comprehensive hemophilia clinic meets weekly at Children's to serve hemophilia patients and their families and function as a diagnostic resource for primary care physicians who suspect a patient might be a "free bleeder."
- Children's participates in the nationwide "Universal Data Collection" project, sponsored by the Centers for Disease Control, which monitors two major complications of bleeding disorders — blood-borne disease and joint disease.
- Children's is an internationally known leader in research in hemophilia/thrombophilia and other inherited hemorrhagic/thrombotic disorders including catheter-related complications and arthroscopic synovectomy.
- A member of the Alliance of Five international research group, along with The Hospital for Sick Children in Toronto, Children's Hospital of Philadelphia, Emory University and the University of Montreal.